Design and synthesis of novel pyrrolo[2,1-c][1,4]benzodiazepine - Imidazole containing polyamide conjugates

Heterocyclic Communications

Volumn 8, Issue 1, 2002, Pages 19-26

  Kumar, Rohtash ^a   Reddy, B S Narayan ^a   Lown, J William ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PYRROLO[2,1 C][1,4]BENZODIAZEPINE DERIVATIVE; PYRROLO[2,1 C][1,4]BENZODIAZEPINE IMIDAZOLE CONJUGATE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG DESIGN; DRUG DNA BINDING; DRUG SYNTHESIS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ROOM TEMPERATURE; X RAY DIFFRACTION;

EID: 0036011630     PISSN: 07930283     EISSN: None     Source Type: Journal    
DOI: 10.1515/HC.2002.8.1.19     Document Type: Article

References (19)

1. Hurley, L.H.; Thurston, D.E. Pharm. Res. 52 (1984).; Hurley, L.H. J. Antibiot. 30, 349 (1977); Aoki, H.; Miyairi, N.; Ajisaka, M.;Sakai, H. J. Antibiot. 22, 201 (1969)
2. Hurley, L.H.; Thurston, D.E. Pharm. Res. 52 (1984).; Hurley, L.H. J. Antibiot. 30, 349 (1977); Aoki, H.; Miyairi, N.; Ajisaka, M.;Sakai, H. J. Antibiot. 22, 201 (1969)
3. Hurley, L.H.; Thurston, D.E. Pharm. Res. 52 (1984).; Hurley, L.H. J. Antibiot. 30, 349 (1977); Aoki, H.; Miyairi, N.; Ajisaka, M.;Sakai, H. J. Antibiot. 22, 201 (1969)
4. Reddy, B.S.P.; Sondhi, S.M.; Lown, J.W. Pharmacology and Therapeutics. 84, 1 (1999)
5. Miyamoto, M.; Kondo, S.; Naganawa, H.; Maeda, K.; Ohno, M.; Umezawa, H. J. Antibiot. 30, 340 (1977)
6. Remers, W. Antitumor Antibiotics, Wiley and Sons, New York, PP 28-92 (1988); Thurston, D.E. "Advances in the study of Pyrrolo[2,1-c][1,4]benzodiazepine (PBD Antitumor Antibiotics" in Molecular Aspects of Anticancer Drug DNA Interactions,Eds, Neidle, S. and Waring, M.J. Macmillan press Ltd. Pp 54-88 (1993)
7. Remers, W. Antitumor Antibiotics, Wiley and Sons, New York, PP 28-92 (1988); Thurston, D.E. "Advances in the study of Pyrrolo[2,1-c][1,4]benzodiazepine (PBD Antitumor Antibiotics" in Molecular Aspects of Anticancer Drug DNA Interactions,Eds, Neidle, S. and Waring, M.J. Macmillan press Ltd. Pp 54-88 (1993)
8. Hurley, L.H.; Reck, T.; Thurston, D.E.; Longley, D.R.; Holden, K. G.; Faucette, F. Jr.; Mong, S. M.; Johnson, R. K. Chem. Res. Toxicol. 1, 258 (1988)
9. Bose, D. S.; Thompson, A. S.; Smellie, M.; Berardini, M. D.; Hartely, J. A.; Jenkins, T. C.; Neidle, S.; Thurston, D.E. J. Chem. Soc., Chem. Commun. 1518 (1992)
10. Jenkins, T. C.; Hurley, L.H.; Neidle, S.; Thurston, D.E. J. Med. Chem. 37, 4529 (1994)
11. Farmer, J. D.; Rudnicki, S. M. Jr.; Suggs, J. W. Tetrahedron Lett. 29, 5105 (1988)
12. Bose, D. S.; Thompson, A. S.; Ching, J.; Hartely, J. A.; Berardini, M. D.; Jenkins, T. C.; Neidle, S.; Hurley, L.H.; Thurston, D.E. J. Am. Chem. Soc. 114, 4939 (1992)
13. Sondhi, S. M.; Reddy, B. S. P.; Lown, J. W. Curr. Med. Chem. 4, 313 (1997)
14. Lown, J. W.; Joshua, A. V. Biochemical Pharmacology 28, 2017 (1979)
15. Damayanthi, Y.; Reddy, B. S. P.; Lown, J. W. J. Org. Chem. 64, 290 (1999)
16. Rao, K. E.; Lown, J. W. Trends Org. Chem. 3, 141 (1992)
17. Reddy, B. S. P.; Damayanthi, Y.; Reddy, B. S. N.; Lown, J. W. Anti-Cancer Drug Design. 15, 225 (2000)
18. Gupta, R.; Xie, G.; Lown, J. W. Gene. 149, 81 (1994).; Gupta, R.; Wang, H.; Hung, L.; Lown, J. W. Anti-Cancer Drug Design. 10, 25 (1994)
19. Gupta, R.; Xie, G.; Lown, J. W. Gene. 149, 81 (1994).; Gupta, R.; Wang, H.; Hung, L.; Lown, J. W. Anti-Cancer Drug Design. 10, 25 (1994)